Cofepris e IMPI Unen Fuerzas para Fortalecer el Sector Farmacéutico

This agreement between Mexico’s health regulatory and industrial property agencies significantly enhances transparency in sanitary registries and accelerates the availability of essential medicines. By streamlining approval processes and clarifying patent statuses, the initiative reduces bureaucratic delays, ensuring that life-saving treatments reach the population faster and more reliably. The collaboration establishes a clear framework for managing intellectual property rights while facilitating public health objectives. This balance provides legal certainty to pharmaceutical developers and ensures that proprietary interests do not unnecessarily obstruct the timely distribution of healthcare products, thereby strengthening the overall stability of the national health sector. For the open data community, this move is vital as it demonstrates how structured information exchange and published patent lists empower citizens to monitor regulatory efficiency. By making registry statuses and patent timelines more accessible, the agreement sets a precedent for using transparency to improve governance, allowing researchers and the public to better understand and analyze the factors influencing healthcare supply chains.

Source: mundodehoy.com
Published on 2025-02-21